Digital Biomarker Platform for Parkinson's
Early detection and real-time therapeutic monitoring through IMU-observed daily life gait analysis. Better data, better care.
The Problem With Current Diagnostics
Gait movement is an early marker for many diseases. However, current systems rely on subjective feedback and occasional, expensive clinical observations.
Clinical Lab Limitations
Traditional testing is restricted to optimal lab conditions, missing crucial daily real-life movement patterns.
The Cost Barrier
Expensive PET/DAT scans are not scalable for continuous, early detection of neuromuscular disorders.
Unconstrained Assessment
Using wearable IMUs on the wrist and ankle allows for home-based, comfortable monitoring throughout the day.
Longitudinal Data
Capture micro-tremors and subtle gait asymmetry years before visible brain damage occurs.
Real-time AI Processing
Custom IoT pipeline feeds data directly to an AI server, using our 1D CNN model (92% precision) for risk prediction.
Therapeutic Monitoring
Quantify tremor reduction and gait improvement before and after Levodopa to adjust dose timing accurately.
The Minds Behind Vancure
Developing state-of-the-art technology for early Parkinson's detection and therapeutic monitoring.
Monitor Your Health
Anytime, Anywhere.
Get real-time insights into your motor symptoms, track medication efficacy, and easily share your data with your clinician directly from the Vancure mobile app.
